期刊文献+

氯吡格雷与三类药物的联用情况分析 被引量:3

下载PDF
导出
摘要 回顾性调查我院2013年1-6月使用氯吡格雷的内科住院患者出院病历资料136份并进行统计分析。共调查943份内科出院患者病历,136例使用了氯吡格雷,使用率14.42%,其中可能存在药物相互作用的联合用药131例,占96.32%。与氯吡格雷联合用药例数最多的是他汀类药物(130例),其次是质子泵抑制剂(61例),第三位是钙离子拮抗剂(57例)。联用例次数居前三位的药品分别是:阿托伐他汀钙片(129例次)、苯磺酸氨氯地平片(38例次)、雷贝拉唑钠肠溶片(37例次)。
出处 《海峡药学》 2015年第4期204-205,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献5

二级参考文献73

  • 1Porto I, Van Gaal W, Banning A. Impact of the elevation of biochemical markers of myocardial damage on long term mortality after percutaneous coronary intervention: results of theCK MBand PCI study[J]. Eur Heart J, 2005,26(20): 2206-2207.
  • 2Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction[J]. J Am Coll Cardiol, 2009,54 (23) : 2157-2163.
  • 3Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early pereutaneous coronary intervention: results of the ARMYDA ACS randomized trial [J]. J Am Coll Cardiol, 2007,49(12) :1272- 1278.
  • 4Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention : results of the ARMYDA RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial [J]. J AmCollCardiol, 2009,54(6):558 -565.
  • 5Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives[J]. J Am Coll Cardiol, 2007,49(14) :1505 -1516.
  • 6Marian AJ. Cytochrome p-450 polymorphisms and response to clopidogrel[J]. Curr Atheroscler Rep, 2009,11(3):157-160.
  • 7Neubauer H, Gtinesdogan B, Hanefeld C, et al. Lipophilic statins interfere with the inhibitory effects of elopidogrel on platelet function-a flow cytometry study[J]. Eur Heart J, 2003,24(19) : 1744-1749.
  • 8Brophy JM, Babapulle MN, Costa V, et al. A pharmacoe pidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention[J]. Am Heart J, 2006,152(2) :263 -269.
  • 9Saw J, Brennan DM, Steinhubl SR,et al. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial[J]. J Am Coll Cardiol, 2007,50(4):291-295.
  • 10Lim MJ, Spencer FA, Gore JM, et al. Impact of combined pharmacologic treatment with elopidogrel and a statin on outcomes of patients with non-ST segment elevation acute coronary syndromes: perspectives from a large multinational registry[J]. Eur Heart J, 2005, 26(11):1063-1069.

共引文献58

同被引文献40

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部